Creative Biogene Releases Kinase Stable Cell Lines to Support Antibody Development and Drug Discovery

With the support of an innovative portfolio of products and a custom-service-centered business model, Creative Biogene announced the release of its kinase stable cell lines in order to support drug discovery and life science research.

USA – November 2, 2022 /MarketersMEDIA/ —

Creative Biogene, the state-of-the-art institution staffed by some of the best trained and most experienced subject matter experts in the field of biotechnology and life science, is dedicated to providing customized molecular biology reagents and professional technical services to customers. With the support of an innovative portfolio of products and a custom-service-centered business model, Creative Biogene announced the release of its kinase stable cell lines in order to support drug discovery and life science research.

Due to their important cellular functions, kinases have become important drug targets in drug discovery and development for the treatment of human diseases, especially a variety of cancers. These targets include epidermal growth factor receptor (EGFR), vascular endothelial growth factor receptor (VEGFR), fibroblast growth factor receptor (FGFR), erb-b2 receptor tyrosine kinase 2 (ERBB2), platelet-derived Growth factor receptor (PDGFR), kits, ABL, SRC, mTOR, etc. Small-molecule kinase inhibitors targeting these targets have shown prominent roles in the treatment of many cancers.

With decades of experience in cell line engineering and drug discovery, Creative Biogene has developed a number of kinase stable cell lines for in vitro cell-based kinase assays. The use of these cell lines enables a broad range of assays and reduces assay development time:

• EGFR cell lines

• BCR-ABL cell lines

• AXL cell lines

• BTK cell lines

• C-Kit cell lines

• EML4-ALK cell lines

• ETV6-NTRK2 cell lines

• ETV6-NTRK3 cell lines

Gene-overexpressing stable cell lines are one of the widely used tools in biological research, including basic research such as protein engineering, recombinant antibody development, and drug discovery. Creative Biogene provides stable expression of the gene of interest (GOI) via plasmid transfection or lentiviral transduction. The scientists have many years of experience in achieving gene overexpression stable cell lines, including GPCR, reporter gene and ion channel stable cell lines. 

“We have successfully generated hundreds of stable cell lines, including gene knockout, gene overexpression, and gene knockout cell lines.” said Marcia Brady, the marketing director of Creative Biogene, she also added, “Our products are fully prepared to meet customer requirements, and the customized cell generation projects are managed by experienced scientists from design to delivery.”

About Creative Biogene

Creative Biogene, as a top-of-its-kind company that holds a leading position and is committed to accelerating the development of human science through biotechnology, offering innovative technologies, products, unique tools and services for research discoveries and product development. With more than 10 years of experience and in-house experts, Creative Biogene has become a well-recognized industry leader to support researchers worldwide.

Contact Info:
Name: Marcia Brady
Email: Send Email
Organization: Creative Biogene
Address: Shirley, NY 11967, USA
Phone: 6313868241
Website: https://www.creative-biogene.com/

Release ID: 89084157

If you detect any issues, problems, or errors in this press release content, kindly contact error@releasecontact.com to notify us. We will respond and rectify the situation in the next 8 hours.